ProGen Biologics is a four years old biotechnology company that specializes in developing health care solutions in areas such as autoimmunity, cardiovascular and infectious diseases. Company markets and provides services to measure humoral immune responses in disease pathology. The company has developed a robust proteomic platform for the analysis of human plasma and plasma molecules involved in disease pathology.
Company has active research programs to study complement molecules and circulating immune complexes, the key inflammatory molecules. Based on these research activities the company has developed a robust portfolio of intellectual property.
Company currently markets research diagnostic products and is working in collaboration with several reputed research groups in US and Europe in designing and developing heatlhcare solutions.